hca healthcare inc. - HCA

HCA

Close Chg Chg %
446.84 21.01 4.70%

Closed Market

467.85

+21.01 (4.70%)

Volume: 1.79M

Last Updated:

Oct 27, 2025, 3:59 PM EDT

Company Overview: hca healthcare inc. - HCA

HCA Key Data

Open

$450.75

Day Range

448.80 - 469.18

52 Week Range

290.05 - 461.56

Market Cap

$104.60B

Shares Outstanding

233.99M

Public Float

166.32M

Beta

1.41

Rev. Per Employee

N/A

P/E Ratio

17.28

EPS

$19.13

Yield

63.08%

Dividend

$0.72

EX-DIVIDEND DATE

Dec 15, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

1.29M

 

HCA Performance

1 Week
 
4.90%
 
1 Month
 
6.67%
 
3 Months
 
33.72%
 
1 Year
 
22.97%
 
5 Years
 
260.69%
 

HCA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 28
Full Ratings ➔

About hca healthcare inc. - HCA

HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.

HCA At a Glance

HCA Healthcare, Inc.
One Park Plaza
Nashville, Tennessee 37203-6527
Phone 1-615-344-9551 Revenue 70.60B
Industry Hospital/Nursing Management Net Income 5.76B
Sector Health Services 2024 Sales Growth 8.674%
Fiscal Year-end 12 / 2025 Employees 316,000
View SEC Filings

HCA Valuation

P/E Current 18.489
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 13.643
Price to Sales Ratio 1.113
Price to Book Ratio N/A
Price to Cash Flow Ratio 7.47
Enterprise Value to EBITDA 9.009
Enterprise Value to Sales 1.768
Total Debt to Enterprise Value 0.362

HCA Efficiency

Revenue/Employee 223,427.215
Income Per Employee 18,227.848
Receivables Turnover 6.54
Total Asset Turnover 1.22

HCA Liquidity

Current Ratio 1.082
Quick Ratio 0.967
Cash Ratio 0.133

HCA Profitability

Gross Margin 14.938
Operating Margin 14.938
Pretax Margin 12.072
Net Margin 8.158
Return on Assets 9.955
Return on Equity N/A
Return on Total Capital 13.477
Return on Invested Capital 15.361

HCA Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 105.847
Total Debt to Total Assets 76.012
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 94.052
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Hca Healthcare Inc. - HCA

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
58.75B 60.23B 64.97B 70.60B
Sales Growth
+14.01% +2.52% +7.86% +8.67%
Cost of Goods Sold (COGS) incl D&A
49.07B 51.18B 55.34B 60.06B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
2.85B 2.97B 3.08B 3.31B
Depreciation
2.83B 2.94B 3.05B 3.29B
Amortization of Intangibles
27.00M 28.00M 25.00M 18.00M
COGS Growth
+10.85% +4.29% +8.13% +8.52%
Gross Income
9.68B 9.05B 9.63B 10.55B
Gross Income Growth
+33.27% -6.46% +6.34% +9.56%
Gross Profit Margin
+16.47% +15.03% +14.82% +14.94%
2021 2022 2023 2024 5-year trend
SG&A Expense
- - - -
-
Research & Development
- - - -
-
Other SG&A
- - - -
-
SGA Growth
- - - -
-
Other Operating Expense
- - - -
-
Unusual Expense
- - 12.00M 78.00M
-
EBIT after Unusual Expense
9.67B 8.97B 9.63B 10.55B
Non Operating Income/Expense
1.70B 1.34B 17.00M 37.00M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
113.00M 45.00M 22.00M 23.00M
Interest Expense
1.53B 1.74B 1.94B 2.06B
Interest Expense Growth
-1.99% +13.73% +11.44% +6.35%
Gross Interest Expense
1.53B 1.74B 1.94B 2.06B
Interest Capitalized
- - - -
-
Pretax Income
9.83B 8.58B 7.71B 8.52B
Pretax Income Growth
+81.09% -12.74% -10.19% +10.60%
Pretax Margin
+16.74% +14.24% +11.86% +12.07%
Income Tax
2.11B 1.75B 1.61B 1.87B
Income Tax - Current - Domestic
2.08B 1.43B 1.33B 1.41B
Income Tax - Current - Foreign
15.00M 18.00M 3.00M 20.00M
Income Tax - Deferred - Domestic
6.00M 288.00M 262.00M 425.00M
Income Tax - Deferred - Foreign
11.00M 12.00M 19.00M 7.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
113.00M 45.00M 22.00M 23.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
7.72B 6.83B 6.09B 6.66B
Minority Interest Expense
765.00M 1.19B 849.00M 897.00M
Net Income
6.96B 5.64B 5.24B 5.76B
Net Income Growth
+85.30% -18.88% -7.11% +9.88%
Net Margin Growth
+11.84% +9.37% +8.07% +8.16%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
6.96B 5.64B 5.24B 5.76B
Preferred Dividends
- - - -
-
Net Income Available to Common
6.96B 5.64B 5.24B 5.76B
EPS (Basic)
21.5146 19.4353 19.2435 22.2735
EPS (Basic) Growth
+93.87% -9.66% -0.99% +15.75%
Basic Shares Outstanding
323.31M 290.35M 272.40M 258.60M
EPS (Diluted)
21.1588 19.1505 18.9644 22.001
EPS (Diluted) Growth
+93.67% -9.49% -0.97% +16.01%
Diluted Shares Outstanding
328.75M 294.67M 276.41M 261.81M
EBITDA
12.53B 12.02B 12.70B 13.86B
EBITDA Growth
+25.52% -4.06% +5.67% +9.09%
EBITDA Margin
+21.33% +19.96% +19.55% +19.63%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 474.048
Number of Ratings 28 Current Quarters Estimate 7.409
FY Report Date 12 / 2025 Current Year's Estimate 27.327
Last Quarter’s Earnings 6.96 Median PE on CY Estimate N/A
Year Ago Earnings 21.96 Next Fiscal Year Estimate 29.626
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 21 15 23 23
Mean Estimate 7.41 7.16 27.33 29.63
High Estimates 7.68 7.60 27.90 31.42
Low Estimate 6.40 6.79 25.63 26.35
Coefficient of Variance 3.52 3.07 2.46 4.68

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 14 13 13
OVERWEIGHT 1 1 2
HOLD 11 12 13
UNDERWEIGHT 2 2 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Hca Healthcare Inc. in the News